EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Performance of the Self‐Controlled Case Series for Drug Safety Signal Detection: A Multi‐Database Study

Astrid Coste iD, Angel Y S Wong iD, Francois Haguinet, Andrew Bate iD, Ian J Douglas

Pharmacoepidemiology and Drug Safety · 2026

DOI: 10.1002/pds.70298 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2026. Verfasst von Astrid Coste und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Non-Communicable Diseases Epidemiology, LSHTM, London, UK. Hauptthemen laut MEDLINE: Databases, Factual, Adverse Drug Reaction Reporting Systems, Anti-Bacterial Agents, Drug-Related Side Effects and Adverse Reactions. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GlaxoSmithKline.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Differences in performance of the Self‐Controlled Case Series (SCCS) for signal detection have been reported across different databases. However, there has been limited comparative analysis of performance and it remains unknown whether combinations of databases could enable more effective signal detection.

Objectives

This study aims to compare the performance of the SCCS for signal detection across several data sources, and to determine whether combinations of databases can improve SCCS performance.

Methods

We applied the SCCS to macrolides and fluoroquinolone antibiotics, in four databases: Merative MarketScan Commercial Claims and Medicare, the Clinical Practice Research Datalink (CPRD) Aurum and the Système National des Données de Santé. We developed a reference set of 104 positive controls and 58 negative controls, using a taxonomy framework to ensure the selected drug outcome pairs are theoretically well suited to the SCCS design. The observation period lasted 2 years, with a 30‐day risk‐window after each dispensing. Diagnostic performance was measured using sensitivity, specificity and area under the receiver operating curve (AUC) with respect to the product labels, both for individual and combinations of databases.

Results

The sensitivity of the SCCS ranged from 0.57–0.89 across individual databases, and the specificity from 0.43–0.77 when limited to drug‐outcome pairs sufficiently powered. The combination of all databases achieved the maximum sensitivity of 0.89 (0.41 specificity) for the full reference set, and a sensitivity of 1 (0.35 specificity) for drug outcome pairs with enough power. Whilst AUCs ranged from 0.66 to 0.71 across individual databases, the highest performing combination was CPRD plus MarketScan Commercial Claims (0.76 AUC).

Conclusions

Using a carefully designed reference set of drug‐outcome pairs well suited to the study design, the SCCS performance varied substantially by database due to differences in population, reporting, healthcare and coding systems and prescribing patterns. Multi‐database studies showed increased performance of SCCS for signal detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Databases, FactualAdverse Drug Reaction Reporting SystemsAnti-Bacterial AgentsDrug-Related Side Effects and Adverse ReactionsHumansUnited StatesFluoroquinolonesSensitivity and SpecificityMedicareArea Under CurvePharmacovigilance

Stichwörter der Autor:innen

claims dataelectronic health recordspharmacoepidemiologypharmacovigilancereal‐world dataself‐controlled case seriessignal detection

Substanzen

Anti-Bacterial AgentsFluoroquinolones

Autor:innen und Institutionen

  • Department of Non-Communicable Diseases Epidemiology, LSHTM, London, UK.
  • GSK, London, UK.

ORCID-Profile: Astrid Coste, Angel Y S Wong, Andrew Bate

Förderung

  • GlaxoSmithKline

Zitieren

APA

Coste, A., Wong, A. Y. S., Haguinet, F., Bate, A., & Douglas, I. J. (2026). Performance of the Self‐Controlled Case Series for Drug Safety Signal Detection: A Multi‐Database Study. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70298

Vancouver

Coste A, Wong AYS, Haguinet F, Bate A, Douglas IJ. Performance of the Self‐Controlled Case Series for Drug Safety Signal Detection: A Multi‐Database Study. Pharmacoepidemiology and Drug Safety. 2026. doi:10.1002/pds.70298

BibTeX
@article{Coste2026,
  author = {Coste, Astrid and Wong, Angel Y S and Haguinet, Francois and Bate, Andrew and Douglas, Ian J},
  title = {Performance of the Self‐Controlled Case Series for Drug Safety Signal Detection: A Multi‐Database Study},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2026},
  doi = {10.1002/pds.70298}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche